Cann Pharmaceutical

    Cann Pharmaceutical
    Cann Pharmaceutical
    Barton, ACT 2600, Australia

    Our global vision: Global medicine, Pharmaceutical quality.

    Medicinal Products

    Cann Pharma is market ready in Australia – with a drug portfolio of 16 existing medicinal grade cannabis products recommended by physicians and used by patients in Israel today for a myriad of medical diseases and conditions.

    Cann Pharmaceutical Ltd of Israel has ten years of licensed experience in Israel and is one of few global 100% organic, chemical free producers of phytocannabinoid products.

    We have a pathway for patients to secure access to our market ready and proprietary Cannabidiol (CBD) Enriched Epilepsy treatment EP1 from imports.

    EP1 is our lead product for drug resistant epilepsy (DRE) in children, adolescents and adults.

    Cann Pharma has a large number of proprietary strains that will be 100% organically cultivated and manufactured in Australia into proven phytocannabinoid pharmaceutical-grade drugs and treatments for specific medical conditions.

    Other medical conditions we have medicinal cannabis treatments for include: Autism, Central Nervous System Pain, Palliative Care, PTSD and certain Cancers.

    Our clinical study pipeline is designed to leverage the ten years of clinical experience of doctors and patients.

    PublishedDirectory Free TierClaimed
    Previous articleTasCann Limited
    Next articleCannOz
    Mitch Keys is a young writer from Brisbane, Australia unfolding in a dynamic process of becoming (like everyone else, so don’t go thinking he’s special or anything). He likes being alive.
    Notify of
    Inline Feedbacks
    View all comments
    Would love your thoughts, please comment.x